Jim Cramer Commented on 13 Stocks Like Meta and Yum! Brands
In this article, we will look at the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings.
Immunitybio Inc. (IBRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 12,571,597 | $96,424,149 | 0.06% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 4,385,500 | $33,636,785 | +284% | 0.03% |
| 3. | 3,824,900 | $29,336,983 | 0.06% | ||
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,447,346 | $26,441,144 | +1% | 0.1% |
| 5. | 3,000,800 | $23,016,136 | 5.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 485 | $1,333.75 | 71,915 | 2023-06-05 | Filing | |
| $2.77 | 48,000 | $132,960.00 | 71,430 | 2023-06-05 | Filing | |
| $2.72 | 23,430 | $63,729.60 | 23,430 | 2023-06-05 | Filing | |
| $2.90 | 10,000 | $29,000.00 | 25,000 | 2023-06-02 | Filing | |
| $2.80 | 10,000 | $28,000.00 | 15,000 | 2023-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 1,000 | $9,000.00 | 0 | 2026-06-30 | Filing | |
| $9.01 | 95,722 | $862,215.92 | 0 | 2026-06-29 | Filing | |
| $7.88 | 25,000 | $196,907.50 | 2,802,788 | 2026-06-24 | Filing | |
| $7.18 | 23,033 | $165,305.54 | 2,827,788 | 2026-06-04 | Filing | |
| $12.01 | 75,000 | $900,787.50 | 2,850,821 | 2026-02-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 157,200 | $1,376,286 | 0.28% | |
| 2. | 29,020 | $254,070 | 0.05% | |
| 3. | 262 | $2,294 | 0% |
News See All
10 Best Performing Growth Stocks So Far in 2026
On June 9, CNBC reported that global stock markets moved slightly higher as investors looked for signs of recovery from recent market volatility caused by a sharp sell-off in tech stocks.
10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now
Small cap and mid cap stocks have been on a roll in the first half of the year as investors rotate away from mega cap tech stocks.
Is ImmunityBio Inc. (IBRX) One of the Best Momentum Stocks to Buy According to Analysts?
ImmunityBio Inc. (NASDAQ:IBRX) is one of the best momentum stocks to buy according to analysts. ImmunityBio Inc. (NASDAQ:IBRX) announced on May 19 that the U.S.
10 Best Mid Cap Stocks to Buy with Highest Upside Potential
On May 16, Alex Guiliano, CIO of Resonate Wealth Partners, joined BNN Bloomberg to discuss the economic landscape and portfolio strategies following the confirmation of Kevin Warsh as the new US Fed Chair...
10 Best Momentum Stocks to Buy According to Analysts
On May 22, Steve Sosnick, from Interactive Brokers, appeared on CNBC’s ‘Power Lunch’ to talk about what is driving the record market moves.
Is ImmunityBio, Inc. (IBRX) A Good Stock To Buy Now?
Is IBRX a good stock to buy? We came across a bullish thesis on ImmunityBio, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares.
10 Best Stocks to Buy in a Rising Market According to Wall Street Analysts
The equity market remains bullish, driven by a record-setting trend fueled by renewed enthusiasm for artificial intelligence.
ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia
TheFly reported on April 21 that ImmunityBio, Inc.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more stable foundation.